TY - JOUR
T1 - Risk and response adapted treatment guidelines for managing first relapsed and refractory classical hodgkin lymphoma in children and young people. Recommendations from the EuroNet pediatric hodgkin lymphoma group
AU - Daw, Stephen
AU - Hasenclever, Dirk
AU - Mascarin, Maurizio
AU - Fernández-Teijeiro, Ana
AU - Balwierz, Walentyna
AU - Beishuizen, Auke
AU - Burnelli, Roberta
AU - Cepelova, Michaela
AU - Claviez, Alexander
AU - Dieckmann, Karin
AU - Landman-Parker, Judith
AU - Kluge, Regine
AU - Körholz, Dieter
AU - Mauz-Körholz, Christine
AU - Wallace, William Hamish
AU - Leblanc, Thierry
N1 - Publisher Copyright:
© 2020 Wolters Kluwer Health. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or refractory (R/R) classical Hodgkin lymphoma (cHL). While salvage with standard dose chemotherapy followed by high dose chemotherapy and autologous stem cell transplant is often considered the standard of care in adult practice, pediatric practice adopts a more individualized risk stratified and response adapted approach to salvage treatment with greater use of non-transplant salvage. Here, we present on behalf of the EuroNet Pediatric Hodgkin Lymphoma group, evidence and consensus-based guidelines for standardized diagnostic, prognostic and response procedures to allocate children and adolescents with R/R cHL to stratified salvage treatments.
AB - The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or refractory (R/R) classical Hodgkin lymphoma (cHL). While salvage with standard dose chemotherapy followed by high dose chemotherapy and autologous stem cell transplant is often considered the standard of care in adult practice, pediatric practice adopts a more individualized risk stratified and response adapted approach to salvage treatment with greater use of non-transplant salvage. Here, we present on behalf of the EuroNet Pediatric Hodgkin Lymphoma group, evidence and consensus-based guidelines for standardized diagnostic, prognostic and response procedures to allocate children and adolescents with R/R cHL to stratified salvage treatments.
UR - http://www.scopus.com/inward/record.url?scp=85090989060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090989060&partnerID=8YFLogxK
U2 - 10.1097/HS9.0000000000000329
DO - 10.1097/HS9.0000000000000329
M3 - Article
AN - SCOPUS:85090989060
VL - 4
JO - HemaSphere
JF - HemaSphere
SN - 2572-9241
IS - 1
M1 - e329
ER -